Oloblu OD 0.2% Eye Drops 5ml

Eye conditions Rx required
NOT AVAILABLE

Best Price*  ₹ 92.00
MRP ₹115.00
(Inclusive of all taxes) * Mkt: Lupin Ltd * Country of Origin: NA * Delivery charges if applicable will be applied at checkout



INTRODUCTION

OLOBLU OD 0.2% contain olopatadine which belongs to a group of medicine called antihistamines. It is used to treat signs and symptoms of seasonal allergic conjunctivitis. Seasonal allergic conjunctivitis is one of the most common eye problems, affecting about one fifth of adults. It is caused due to an airborne substance called allergen that reaches the surface of the eye and sets off an allergic reaction.

OLOBLU OD 0.2% works by blocking the action of a chemical messenger (histamine) which is responsible for itching, redness as well as swelling of the surface of your eye. The common side effects are eye pain, eye irritation, dry eye, abnormal eye sensation, eye discomfort, headache, fatigue, dry nose, bad taste. This medicine is only for ophthalmic use.

Always use OLOBLU OD 0.2% exactly as your doctor has told you. Check the label for directions before use. It is strictly not recommended for use in children under the age of 3 years. Before using this medicine tell your doctor if you have ever had kidney disease, heart disease, liver problems. Pregnant and breastfeeding women should consult their doctor before using this medicine.

USES OF OLOBLU OD 0.2%

  • Treat signs and symptoms of seasonal allergic conjunctivitis

HOW OLOBLU OD 0.2% WORKS

OLOBLU OD 0.2% works by blocking the action of a chemical messenger (histamine) which is responsible for itching, redness as well as swelling of the surface of your eye.

DIRECTIONS FOR USE

Always use OLOBLU OD 0.2% exactly as your doctor has told you. Check the label for directions before use.

SIDE EFFECTS OF OLOBLU OD 0.2%

COMMON

  • eye pain, eye irritation, dry eye, abnormal eye sensations, eye discomfort
  • headache
  • fatigue
  • dry nose
  • bad taste

HOW TO MANAGE SIDE EFFECTS

Headache:

Apply hot or cold-water bag on your head. Take rest in a quiet and dark room. Drink tea or coffee.

WARNING & PRECAUTIONS

PREGNANCY

OLOBLU OD 0.2% should be used with caution in pregnant women. Consult your doctor before taking.

BREASTFEEDING

OLOBLU OD 0.2% is not recommended for use in breastfeeding women unless necessary. Discuss the risks and benefits with your doctor.

DRIVING AND USING MACHINES

Do not drive or operate machinery while taking this medicine, since it may cause blurred vision.

ALLERGY

Do not take OLOBLU OD 0.2% if you are allergic (hypersensitive) to olopatadine or any other ingredients in this medicine.

OTHERS

Tell your doctor, if you:

  • are using contact lenses

INTERACTIONS

Tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription especially any other eye drops or eye ointment.

SYNOPSIS

Drug :   Olopatadine
Pharmacological Category :   Histamine H1 Antagonist, Second Generation, Piperidine Derivative
Therapeutic Indication :   Signs and symptoms of seasonal allergic conjunctivitis
Dosage Forms :   Tablet, Eye drops

MORE INFORMATION

Store below 20-25°C and keep out of reach of children.

FAQs ABOUT OLOBLU OD 0.2%

Can OLOBLU OD 0.2% be given in children?

It is strictly not recommended for use in children under the age of 3 years.

Is OLOBLU OD 0.2% effective?

Yes, it is effective if used in the dose and duration as advised by your doctor.

Does OLOBLU OD 0.2% make you sleepy?

A bitter taste in the mouth, nosebleeds, or irritation/soreness in the nose may occur. Drowsiness may rarely occur. If any of these effects persist or worsen, tell your doctor.

REFERENCES

1. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. Page - 2855-2856.

2. Yingxin Zi 1 2, Yu Deng 1 2, Meiqi Ji 1 2, Yali Qin 1 2, Luqi Nong 1 2, Ziqiang Liu 1 2, Ming Jin 2. The effectiveness of olopatadine hydrochloride eye drops for allergic conjunctivitis: Protocol for a systematic review. NIH: National Library of Medicine, National center of biotechnology Information Pubmed.gov. Feb 2020. [Accessed 02 Jan 2021] https://pubmed.ncbi.nlm.nih.gov/32049778/

3. S.A. Alcon-Couvreur N.V; Electronic Medicines Compendium (EMC); [Revised on Nov 2020] [Accessed 02 Jan 2021] https://www.medicines.org.uk/emc/files/pil.6768.pdf

PRODUCT DETAILS

    Net Qty
    1
    Ingredient
    OLOPATADINE 0.2 %
    Hsn Code
    30049099
DISCLAIMER

The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright© 2021. All Rights Reserved.